---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "FIIrmpqFULzjj2cLn+PbzQxFrTZ0bH2pFqhPwaK8IQkAY74d8B7TyrrLT2pnNvUkj6nG599Q4y6M/N1QY2Pqt/7Bhmk/vuhcIpQylKbzATPWBBSwl1b31J8rbKgBN7eBKLXY+xT9zRUWK9XXdmaGan6fzziUWaznmUybWblv6d33cLZdS2W3FkCx/+9SnSsvR3hTEmhWDVia17Jtt3EY+pFb1nvHzL9bnbNDRFFSv/Pt++DyuyPjbF5E8B1JbgHGHG6w0BkI+/LirDlRq3c11nrpU1LC9EhLbqNm4adlXNXHMifD3FtSrWKKtJnmhXzllUi13q3IbdwevcRNwyF6hw23YI1rNpTBNkpJEni5moE=;A7JJsW2slVqxsMTBYnG8XQ=="
---

